A plethora of pathways, a medley of mediators: how do we tease out pathogenesis

G. Laurent (London, United Kingdom)

Source: Research Seminar 2010 - Novel insights in pulmonary fibrogenesis: from bench to bedside Research Seminar
Number: 24

Slide presentationPDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
G. Laurent (London, United Kingdom). A plethora of pathways, a medley of mediators: how do we tease out pathogenesis. Research Seminar 2010 - Novel insights in pulmonary fibrogenesis: from bench to bedside Research Seminar

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Mitophagy, at the crossroads of genetic pathways involved in sarcoidosis and host-pathogen interactions with SARS-COV2 proteins
Source: Virtual Congress 2021 – Moving forward in various aspects of sarcoidosis
Year: 2021


Pathogenesis of lung cancer signalling pathways: roadmap for therapies
Source: Eur Respir J 2009; 33: 1485-1497
Year: 2009



Dysregulation of host defence peptides by environmental challenge: Can we mitigate the pathophysiology?
Source: International Congress 2019 – Infections, the microbiome and host defence peptides in the development and progression of asthma
Year: 2019


The role of pathophysiological aspects and inflammatory markers in phenotyping COPD
Source: Annual Congress 2010 - PG8 Postgraduate Course: Phenotypes of asthma and COPD
Year: 2010



Activation of proteolytic mechanisms in response to inflammatory stimuli: a possible role in the development of the aleolocapillary barrier damage
Source: Eur Respir J 2003; 22: Suppl. 45, 458s
Year: 2003

PAH and inflammation: its role in pathogenesis - is it of value to modulate it?
Source: Annual Congress 2005 - Challenges in the biological understanding of pulmonary arterial hypertension
Year: 2005

Asthma phenotypes: do metabolic pathways hold the key?
Source: International Congress 2017 – Metabolism in respiratory diseases: time for a rethink
Year: 2017


Some pathogenetic mechanisms of inflammatory processes in smoking patients with COPD
Source: Annual Congress 2007 - Smoking and the lung
Year: 2007


The roles of Th2 cytokines and their signaling pathways in the pathogenesis of non-eosinophilic asthma enhanced by dsRNA
Source: Annual Congress 2006 - Immunological mechanisms in cell recruitment to the lungs
Year: 2006


Signalling mechanisms that regulate lung inflammation in humans
Source: Annual Congress 2004 - Acquired somatic mutations in the pathogenesis of COPD
Year: 2004

The role of certain regulatory cytokines in the immunopathogenesis of extrinsic allergic alveolitis
Source: International Congress 2018 – Asthma, rhinitis and COPD: cells, mediators, biomarkers and genetics
Year: 2018

To the molecular genetic mechanisms of the COPD pathogenesis
Source: International Congress 2018 – Functional genomics and COPD: new challenges
Year: 2018

Long COVID: to investigate immunological mechanisms and sex/gender related aspects as fundamental steps for tailored therapy
Source: Eur Respir J, 59 (2) 2102245; 10.1183/13993003.02245-2021
Year: 2022



Inflammatory pathways in COPD. What we know and potential clinical implications
Source: Annual Congress 2008 - New insights into COPD pathophysiology
Year: 2008


Signalling and transcriptional regulation in inflammatory and immune cells: importance in lung biology and disease
Source: Eur Respir J 2005; 26: 762-763
Year: 2005